These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 37247759

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Implications of critical node-dependent unidirectional cross-talk of Plasmodium SUMO pathway proteins.
    Singh JS, Sajeev T K, Panigrahi R, Cherry P, Panchakshari NA, Shukla VK, Kumar A, Mishra RK.
    Biophys J; 2022 Apr 19; 121(8):1367-1380. PubMed ID: 35331687
    [Abstract] [Full Text] [Related]

  • 23. Protein interactions in the sumoylation cascade: lessons from X-ray structures.
    Tang Z, Hecker CM, Scheschonka A, Betz H.
    FEBS J; 2008 Jun 19; 275(12):3003-15. PubMed ID: 18492068
    [Abstract] [Full Text] [Related]

  • 24. RWD Domain as an E2 (Ubc9)-Interaction Module.
    Alontaga AY, Ambaye ND, Li YJ, Vega R, Chen CH, Bzymek KP, Williams JC, Hu W, Chen Y.
    J Biol Chem; 2015 Jul 03; 290(27):16550-9. PubMed ID: 25918163
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Is Transthyretin a Regulator of Ubc9 SUMOylation?
    Wieczorek E, Kędracka-Krok S, Sołtys K, Jankowska U, Hołubowicz R, Seliga J, Ożyhar A.
    PLoS One; 2016 Jul 03; 11(8):e0160536. PubMed ID: 27501389
    [Abstract] [Full Text] [Related]

  • 27. UHRF2, a ubiquitin E3 ligase, acts as a small ubiquitin-like modifier E3 ligase for zinc finger protein 131.
    Oh Y, Chung KC.
    J Biol Chem; 2013 Mar 29; 288(13):9102-11. PubMed ID: 23404503
    [Abstract] [Full Text] [Related]

  • 28. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH, Kim S, Yu B, Jaffray E, Song J, Zheng J, Rodriguez MS, Hay RT, Chen Y.
    Biochemistry; 2003 Aug 26; 42(33):9959-69. PubMed ID: 12924945
    [Abstract] [Full Text] [Related]

  • 29. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
    Zhang J, Goodson ML, Hong Y, Sarge KD.
    J Biol Chem; 2008 Mar 21; 283(12):7464-9. PubMed ID: 18211895
    [Abstract] [Full Text] [Related]

  • 30. A mechanistic view of the role of E3 in sumoylation.
    Tozluoğlu M, Karaca E, Nussinov R, Haliloğlu T.
    PLoS Comput Biol; 2010 Aug 26; 6(8):. PubMed ID: 20865051
    [Abstract] [Full Text] [Related]

  • 31. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
    Reverter D, Lima CD.
    Nature; 2005 Jun 02; 435(7042):687-92. PubMed ID: 15931224
    [Abstract] [Full Text] [Related]

  • 32. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
    Parker JL, Ulrich HD.
    Biochem J; 2014 Feb 01; 457(3):435-40. PubMed ID: 24224485
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K, Park H, Pandey N, Azuma Y, De Guzman RN.
    J Biol Chem; 2017 Jun 16; 292(24):10230-10238. PubMed ID: 28455449
    [Abstract] [Full Text] [Related]

  • 35. Dynamin interacts with members of the sumoylation machinery.
    Mishra RK, Jatiani SS, Kumar A, Simhadri VR, Hosur RV, Mittal R.
    J Biol Chem; 2004 Jul 23; 279(30):31445-54. PubMed ID: 15123615
    [Abstract] [Full Text] [Related]

  • 36. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
    Chung TL, Hsiao HH, Yeh YY, Shia HL, Chen YL, Liang PH, Wang AH, Khoo KH, Shoei-Lung Li S.
    J Biol Chem; 2004 Sep 17; 279(38):39653-62. PubMed ID: 15272016
    [Abstract] [Full Text] [Related]

  • 37. Chemical Synthesis of Atomically Tailored SUMO E2 Conjugating Enzymes for the Formation of Covalently Linked SUMO-E2-E3 Ligase Ternary Complexes.
    Zhang Y, Hirota T, Kuwata K, Oishi S, Gramani SG, Bode JW.
    J Am Chem Soc; 2019 Sep 18; 141(37):14742-14751. PubMed ID: 31436980
    [Abstract] [Full Text] [Related]

  • 38. SUMOylation of Argonaute-2 regulates RNA interference activity.
    Josa-Prado F, Henley JM, Wilkinson KA.
    Biochem Biophys Res Commun; 2015 Sep 04; 464(4):1066-1071. PubMed ID: 26188511
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion.
    Kim ET, Kim KK, Matunis MJ, Ahn JH.
    Biochem Biophys Res Commun; 2009 Oct 09; 388(1):41-5. PubMed ID: 19635459
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.